Project Grant K25GM163098
- Federal Project Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded a $125,000 Project Grant to Harvard College's Office for Sponsored Programs on February 1, 2026, under the Biomedical Research and Research Training program (CFDA 93.859). The grant funds research into enantioselective hydrochlorination of alkenes through cooperative catalysis and dynamic kinetic resolution of quaternary stereocenters. The primary deliverable is the development of a...
- Summary of Federal Project Grant Award Harvard Medical School received a $877,500 Project Grant award effective April 16, 2025, and expiring January 31, 2030, from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859). The award supports the development and optimization of high-throughput mass spectrometry (MS)-based proteomics pipelines designed to advance the depth, throughput, and quantitative accuracy of...
- Grant Award Summary Northeastern University received a $394,000 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective September 1, 2025, through June 30, 2030. This award supports the development of novel quantum sensor-enhanced magnetic resonance techniques utilizing nitrogen-vacancy (NV) centers in diamond to achieve single-molecule detection capabilities. The research aims to...
- Grant Award Summary Albert Einstein College of Medicine received a $1.1 million Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), awarded April 1, 2025, with completion scheduled for January 31, 2030. The award supports fundamental research investigating protein dynamics associated with intrinsic disorder and their functional roles. The research employs advanced analytical methodologies...
- Federal Project Grant Award Summary The Trustees of Tufts College received a $422,958 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective September 1, 2025, through June 30, 2030. The Ding Laboratory will advance computational drug design methodologies by developing and implementing innovative approaches that integrate molecular simulations with machine learning technologies. The...
- Federal Grant Award Summary Dana-Farber Cancer Institute, Inc. received a $489,500 Project Grant from the National Institute of General Medical Sciences under the Biomedical Research and Research Training program (CFDA 93.859), effective August 1, 2025, through May 31, 2030. The award supports research to advance Nuclear Magnetic Resonance (NMR) capabilities for mechanistic biology applications. The funded research will deliver innovative methodologies and tools designed to expand NMR's...
- Federal Project Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded $125,000 to Harvard Medical School through its Biomedical Research and Research Training program (CFDA 93.859) on July 17, 2025, to support fundamental research into selective Golgi remodeling and cellular homeostasis. The research will elucidate the molecular mechanisms underlying golgiphagy—a selective autophagy pathway mediated by transmembrane proteins YIPF3 and YIPF4—and examine how this...
- Federal Grant Award Summary The National Institute of General Medical Sciences awarded a $371,132 Project Grant to Massachusetts Institute of Technology (MIT) under the Biomedical Research and Research Training program (CFDA 93.859) to develop machine learning-enabled peptide catalysts for stereo- and site-selective carbon-carbon (C-C) bond-forming reactions. The research leverages automated fast-flow peptide synthesis (AFPS) to rapidly produce mid-length peptide catalysts (~40 residues)...
- Federal Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded Stanford University a Project Grant of $410,256 (awarded September 15, 2025; completion July 31, 2030) under the Biomedical Research and Research Training program (CFDA 93.859) to develop generative multiscale models of biomolecular conformational dynamics. The primary deliverables include computational tools that integrate physics-based modeling with artificial intelligence to advance conformational...
- Federal Grant Award Summary Massachusetts Institute of Technology received a $149,264 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective March 1, 2026 through September 24, 2028. The project delivers structural biology research investigating the regulatory mechanisms of human ribonucleotide reductase (RNR), a critical enzyme responsible for synthesizing deoxyribonucleotides essential...
This National Institute of General Medical Sciences (NIGMS) Project Grant of $142,182.00 (awarded February 10, 2026, with completion targeted for January 31, 2031) supports fundamental biomedical research under the Biomedical Research and Research Training program (CFDA 93.859). The grant funds Dr. Seetharam's research at Harvard University to develop innovative methodologies for elucidating biomolecular dynamics through magnetic resonance techniques augmented by machine learning and quantum technologies. The research addresses critical limitations in applying magnetic resonance to large biomolecules under near-physiological conditions by creating a novel analysis workflow capable of extracting actionable information from complex experimental data and establishing protocols for a nanoscale magnetic resonance platform operable at high molecular weights and low concentrations. The project's three specific aims leverage machine learning, quantum computing, and quantum sensing approaches to overcome current sensitivity and resolution constraints in magnetic resonance experiments. Successful completion of this work will enable researchers to better understand post-translational modifications and other fundamental biological processes by significantly expanding the applicability of magnetic resonance techniques, bypassing molecular weight limitations, and circumventing existing sensitivity barriers. This research directly supports NIGMS's mission to increase understanding of biological processes and provide foundational knowledge for advances in disease diagnosis, treatment, and prevention.Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $142.2k | 2/10/26 |